Abstract:Acute kidney injury (AKI) is common in hospital patients. Delayed diagnosis and treatment of AKI due to the lack of efficient early diagnosis is an important cause of its high mortality. While fluorescence imaging seems promising to non-intrusively interrogate AKI-related biomarkers, the low kidney contrast of many fluorophores conferred by their relatively low abundance of distribution in the kidney limits their application for AKI detection. Herein, we discovered a near-infrared fluorophore with inherent kidney-targeting ability. Based on this fluorophore, a fluorogenic probe (KNP-1) was developed by targeting peroxynitrite (ONOO−), which is upregulated at the early onset of AKI. KNP-1 exhibits desirable kidney distribution after intravenous administration and is fluorescent only after activation by ONOO−. These properties lead to excellent kidney contrast imaging results. KNP-1 is capable of detecting both nephrotoxin-induced and ischemia-reperfusion injury-induced AKI in live mice. Temporally resolved imaging of AKI-disease model mice with KNP-1 suggests a gradual increase in renal ONOO− levels with disease progression. Notably, the upregulation of ONOO− can be observed at least 24 h earlier than the clinically popular sCr and BUN methods. Blocking ONOO− generation also proves beneficial. These results highlight the applicability of this inherently tissue targeting-based strategy for designing probes with desirable imaging contrast; potentiate ONOO− as a biomarker and target for AKI early diagnosis and medical intervention; and imply the clinical relevance of KNP-1 for AKI early detection.

A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis, and the development of inhibitor

Dual-Locked Chemiluminescent Probe Enables Precise Imaging and Timely Diagnosis of Colitis Via Chymotrypsin/Vanin-1 Cascade Activation

Visualization-Based Discovery of Vanin-1 Inhibitors for Colitis

A ratiometric fluorescent probe for sensitive determination of the important glycopeptide antibiotic vancomycin

Vanin-1-Activated Chemiluminescent Probe: Help to Early Diagnosis of Acute Kidney Injury with High Signal-to-Noise Ratio through Urinalysis

A hepatocyte-targeting near-infrared ratiometric fluorescent probe for monitoring peroxynitrite during drug-induced hepatotoxicity and its remediation.

An optimized NIR fluorescent probe for visualizing DPP IV and applications in the diagnosis and therapy of inflammatory bowel diseases

A new NIR emission mitochondrial targetable fluorescent probe and its application in detecting viscosity changes in mouse liver and kidney injury

A Highly Sensitive and Selective Near-Infrared Fluorescent Probe for Imaging Peroxynitrite in Living Cells and Drug-Induced Liver Injury Mice

An inherently kidney-targeting near-infrared fluorophore based probe for early detection of acute kidney injury

Rational Construction of a Novel Fluorescent Probe for Imaging Peroxynitrite in the Endoplasmic Reticulum During Drug-Induced Liver Injury

Engineering a highly selective leucine aminopeptidase near-infrared fluorescence probe for early diagnosis of diabetic nephropathy

A novel aminopeptidase N triggered near-infrared fluorescence probe for imaging enzyme activity in cells and mice

In-situ gastritis diagnosis by an oral-administration NIR fluorescent probe with a large Stokes shift and high signal-to-noise ratio

An intestinal-targeting near-infrared probe for imaging nitroreductase in inflammatory bowel disease

A near infrared fluorescent probe for the detection and imaging of prolyl aminopeptidase activity in living cells

Oligo(ethylene Glycol)-Functionalized Squaraine Fluorophore As a Near-Infrared-Fluorescent Probe for the in Vivo Detection of Diagnostic Enzymes

A novel fluorescent probe for real-time imaging of thionitrous acid under inflammatory and oxidative conditions

Lysosome targeting fluorescent probe for NAAA imaging and its applications in the drug development for anti-inflammatory

Activatable near-infrared fluorescent probe triggered by nitroreductase for in vivo ulcerative colitis hypoxia imaging

Urinary Vanin-1 As a Novel Biomarker for Early Detection of Drug-Induced Acute Kidney Injury